Biochemical Engineering Special Interest Group
biological engineering professionals
21 October 2016

Biocon's Malaysia insulin plant will be ready for commercial production in H2

India’s Biocon has been working for six years on a massive, $250 million facility to manufacture insulin in Malaysia and says it will soon produce commercial product there. Biocon Chair Kiran Mazumdar-Shaw made the announcement during an investor call following its earnings release, the Economic Times reports, citing PTI. She said the plant will start making Biocon’s rh-insulin and insulin analogs for the local market and then move into producing product for export. Source: Fierce Pharma 21/10/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).